![Prithviraj Bose: Encouraging to see JAK2 V617F VAF reduction correlate with improved EFS](https://oncodaily.com/pub/uploads/2024/06/GQCe3iVWYAALPAJ.jpg)
Photo from Prithviraj Bose/X
Jun 16, 2024, 12:58
Prithviraj Bose: Encouraging to see JAK2 V617F VAF reduction correlate with improved EFS
Prithviraj Bose, Professor of Leukemia at MD Anderson Cancer Centre, shared on X:
“Encouraging to see JAK2 V617F VAF reduction correlate with improved EFS also with ropeg in PROUD/CONTI-PV as with rux in MAJIC-PV.”
Source: Prithviraj Bose/X
Jun 25, 2024, 15:31